Novel Anticonvulsants: A New Generation of Mood Stabilizers?

REFERENCES

• Post RM. Non-lithium treatment for bipolar disorder. J Clin Psychiatry 1990;51(8,suppl):9–16.
   Google Scholar
• Anonymous. Physicians desk reference. 52nd ed. Montvale, New Jersey: Medical Economics Co, 1998.
   Google Scholar
• Ghaemi SN, Sachs GS, Baldassano CF. Treatment-resistant bipolar disorder: clinical aspects and management. In: Pollack MH, Otto MW, Rosenbaum JF, eds. Challenges in clinical practice: pharmacologic and psychosocial strategies. New York: Guilford, 1996:53–85.
   Google Scholar
• Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996;16(2,suppl1):32S–47S.
   Google Scholar
• Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
   Google Scholar
• Ghaemi SN, Goodwin FK. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empiri- cal literature. J Clin Psychopharmacol 1999;19:354–61.
   PubMedGoogle Scholar
• Ahlfors UG, Baastrup PC, Dencker SJ, Elgen K, Lingjaerde O, Pedersen V, et al. Flupenthixol decanoate in recurrent manic- depressive illness: a comparison with lithium. Acta Psychiatr Scand 1981;64:226–37.
   PubMed Web of Science ®Google Scholar
• Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients: a double-blind study. Arch Gen Psychia- try 1981;38:902–7.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin FK. Is bipolar disorder still underdiagnosed? Are antidepres- sants overutilized? J Affect Disord 1999;52:135–44.
   PubMed Web of Science ®Google Scholar
• IMS Health. National disease and therapeutic index. Plym- outh Meeting, Pennsylvania: IMS Health, 1999.
   Google Scholar
• Sachs GS, Lafer B, Truman CJ, Noeth M, Thibault AB. Lith- ium monotherapy: miracle, myth and misunderstanding. Psychiatr Ann 1994;24:299–306.
   Web of Science ®Google Scholar
• Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403–11.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle ac- celeration: a controversy revisited. Am J Psychiatry 1995; 152:1130–8.
   PubMed Web of Science ®Google Scholar
• Kalin N. Management of the depressive component of bipolar disorder. Depr Anx 1996/1997;4:190–8.
   Google Scholar
• Kukopoulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychophar- makol 1980;13:156–67.
   Google Scholar
• Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397–408.
   PubMed Web of Science ®Google Scholar
• Joffe RT, Young LT, MacQueen GM. A two-illness model of bi- polar disorder. Bipolar Disord 1999;1:25–30.
   Google Scholar
• Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kim- brell TA, et al. Clozapine in bipolar disorder: treatment impli- cations for other atypical antipsychotics. J Affect Disord 1998; 48:91–104.
   PubMed Web of Science ®Google Scholar
• Bowden CL. Role of newer medications for bipolar disorder. J Clin Psychopharmacol 1996;16(2, suppl 1):48S–55S.
   Google Scholar
• Sussman N, Asnis G, Bowden C. Current treatments in bipo- lar disorder. CNS Spectr 1998;3:55–61.
   Google Scholar
• Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145–8.
   PubMed Web of Science ®Google Scholar
• Fogelson DL, Sternbach H. Lamotrigine treatment of refrac- tory bipolar disorder. J Clin Psychiatry 1997;58:271–3.
   PubMedGoogle Scholar
• Calabrese JR, Bowden CL, McElroy SL, Cookson J, Andersen J, Keck PE Jr, et al. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 1999; 156:1019–23.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, Rhodes LJ, Keck PE Jr, Cookson J, et al. The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder. Biol Psy- chiatry 1999;45:953–8.
   PubMed Web of Science ®Google Scholar
• Hoopes S. Lamotrigine in the treatment of bipolar depression and other affective disorders: clinical experience in 218 pa- tients [Abstract]. Bipolar Disord 1999;1(suppl 1):35.
   Google Scholar
• Fatemi SH, Rapport DJ, Calabrese JR, Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522–7.
   PubMed Web of Science ®Google Scholar
• Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cy- cling bipolar disorder [Letter]. Am J Psychiatry 1997;154:1171–2.
   PubMedGoogle Scholar
• Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psycho- pharmacol 1997;17:185–9.
   PubMed Web of Science ®Google Scholar
• Labbate LA, Rubey RN. Lamotrigine for treatment-refractory bipolar disorder [Letter]. Am J Psychiatry 1997;154:1317.
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamo- trigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79–88.
   Google Scholar
• Frye M, Ketterer T, Osuch E, Post R. Gabapentin and lamo- trigine monotherapy in mood disorder: an update. Presented at the 151st annual meeting of the American Psychiatric Asso- ciation, Toronto, May 1998.
   Google Scholar
• Ichim L, Berk M, Brook S. Lamotrigine compared to lithium in mania: a double-blind randomised controlled trial. Pre- sented at the 21st Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Glasgow, Scotland, July 1998.
   Google Scholar
• Bennett J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders [Letter]. J Clin Psycho- pharmacol 1997;17:141–2.
   PubMed Web of Science ®Google Scholar
• Young LT, Robb J, Patelis-Siotis I, MacDonald C, Joffe RT. Ga- bapentin in bipolar depression: a case series. Presented at the 150th annual meeting of the American Psychiatric Association, San Diego, May 1997.
   Google Scholar
• Schaffer CB, Schaffer LC. Gabapentin in the treatment of bi- polar disorder [Letter]. Am J Psychiatry 1997;154:291–2.
   PubMedGoogle Scholar
• Knoll J, Stegman K, Suppes T. Clinical experience using gaba- pentin adjunctively in patients with a history of mania or hy- pomania. J Affect Disord 1998;49:229–33.
   PubMed Web of Science ®Google Scholar
• Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar dis- order [Letter]. J Neuropsychiatry Clin Neurosci 1997;9:301.
   Web of Science ®Google Scholar
• Altshuler LL, Keck PE, McElroy SL, Suppes T, Brown ES, De- nicoff K, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999;1:61–5.
   PubMedGoogle Scholar
• Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psy- chiatry 1998;59:426–9.
   Google Scholar
• Marcotte DB, Fogleman L, Wolfe N, Nemire R. Gabapentin: an effective therapy for patients with bipolar affective disorder. Presented at the 150th annual meeting of the American Psychi- atric Association, San Diego, May 1997.
   Google Scholar
• Pande A. Combination treatment in bipolar disorder [Ab- stract]. Bipolar Disord 1999;1(suppl 1):17.
   Google Scholar
• Sabers A, Gram L. Drug treatment of epilepsy in the 1990s: achievements and new developments. Drugs 1996;52:483–93.
   PubMed Web of Science ®Google Scholar
• Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998;50:245–51.
   PubMed Web of Science ®Google Scholar
• Rosenfeld WE. Topiramate: a review of preclinical, pharmaco- kinetic, and clinical data. Clin Ther 1997;6:1294–308.
   Google Scholar
• Markind JE. Topiramate: a new antiepileptic drug. Am J Health Syst Pharm 1998;55:554–62.
   PubMed Web of Science ®Google Scholar
• Calabrese J, Shelton J, Keck P, McElroy S, Werkner J. Topira- mate in severe treatment-refractory mania. Presented at the 151st annual meeting of the American Psychiatric Association, Toronto, Ontario, May 1998.
   Google Scholar
• Chengappa KNR, Rathore D, Levine J, Atzert R, Solai L, Pare- pally H, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42–53.
   Google Scholar